Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
US7033826B2 · kind B2 · utility
29Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2002 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | Sep 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/15
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.